Quris Technologies
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
114 Yigal Alon St, Tel Aviv, Tel Aviv, I...Website
www.quris.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Quris Technologies
Founded in 2020, Quris has created the Bio-AI Clinical Prediction Platform to better predict which drug candidates will safely work in humans. Quris is headquartered in Tel-Aviv, Israel.Explore more
Quris Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quris Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Quris Technologies had a recent Job posting/layoffs
Product Launch: Get notified when Quris Technologies launches new products
Check if Quris Technologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Quris Technologies recently announced quarterly report
Check out if Quris Technologies is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Quris Technologies
Funding: Get notified immidiatlly once Quris Technologies has new funding data
Quris Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Quris Technologies
Find more new buyers
Company Profile Activity
Activity Insights
Quris Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Quris Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Quris Technologies.
Quris Technologies financials insights
Gather financial insights about Quris Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$9M
Quris Technologies Tech Stack
A closer look at the technologies used by Quris Technologies
Most Recent Scoops
Event
Cloud, Product Marketing, Events, Infrastructure, Engineering, Clinical Systems, Data Management, Data Science, Machine Learning, Sales, Enterprise Software, Software, Bioengineering, Pharmaceuticals, Field /Outside Sales, Artificial Intelligence, Clinical Operations, Field Marketing, Healthcare Technology, Operations
Project
Research & Development, Clinical Systems, Sales, Enterprise Software, Software, Medical Research, Artificial Intelligence
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Event
Events
Award
Award
Quris Technologies News & Media
Quris-AI Acquires Nortis
Adds Proven Kidney-on-Chip Technology to Its Pioneering Bio-AI Platform Adds Proven Kidney-on-Chip Technology to Its Pioneering Bio-AI PlatformQuris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi
Abu Dhabi-based collaboration to focus on accelerating the development of new personalized medications using AI Abu Dhabi-based collaboration to focus on accelerating the development of new personalized medications using AIQuris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
AI Innovator Expands Seed Funding to $37 Million With Latest $9 Million Investment, Strengthening Momentum to Close Drug Development Gaps AI Innovator Expands Seed Funding to $37 Million With Latest $9 Million Investment, Strengthening Momentum to Close Drug Development GapsMerck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, allowing Merck KGaA, Darmstadt, Germany to assess Quris’ BioAI safety prediction platform, comparing it to traditional in vitro and in vivo approaches.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quris Technologies
Sign Up For FreeTo access detailed company insights
Founded in 2020, Quris has created the Bio-AI Clinical Prediction Platform to better predict which drug candidates will safely work in humans. Quris is headquartered in Tel-Aviv, Israel.... Read More
